✦ LIBER ✦

P537 Early predictors of long term clinical response to adalimumab in Crohn's disease

✍ Scribed by Martinato, M.; Slongo, T.; Piovanello, M.; Rigato, M.; Ugoni, A.; Frankovic, I.; Caccaro, R.; Sturniolo, G.C.; D'Incà, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.02.8 EARLY PREDICTORS OF LONG TERM CLI

✍ Martinato, M.; Slongo, T.; Piovanello, M.; Rigato, M.; Ugoni, A.; Krankovic, I.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Long-term durability of response to adal

✍ M. Chaparro; J. Panés; V. García; O. Merino; P. Nos; E. Domènech; M. Peñalva; E. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 819 KB

W1275 Long-Term Durability of Response t

✍ Chaparro, Maria; Panes, Julian; García, V.; Merino, Olga; Nos, Pilar; Domènech, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

P426 Long-term safety of adalimumab in p

✍ Rosh, J.; Ruemmele, F.; Dubinsky, M.; Escher, J.; Kierkus, J.; Hyams, J.; Lazar, 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 64 KB

Adalimumab works long term to heal fistu

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

P.01.20 SAFETY OF LONG-TERM INFLIXIMAB A

✍ Mazzuoli, S.; Regano, N.; Guglielmi, F.W. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB